spacer
home > ict > autumn 2016 > coming to you
PUBLICATIONS
International Clinical Trials

Coming to You

Finding patients who are not only willing to participate, but who can work both their personal and professional schedules around a clinical trial’s requirements, has grown increasingly difficult. Obstacles to overcome include the length of time required to source and keep such patients – especially when the studies are of a global nature – as well as unpredictable delays to the trial itself. Ensuring that timelines match with expectations, particularly when time is critical, has a decided impact on a manufacturer’s bottom line. By moving the trials from a hospital setting into patients’ homes, it becomes easier to recruit subjects and allows for faster completion of important studies.

At the Centre


Researchers are seeing the benefit of a patient-centric approach employing the direct-to-patient (DtP) model in order to address these challenges and move studies ahead more effectively. This approach not only puts participants at the centre of the trial experience, but is also designed to reduce inconvenience for them and their families as the study goes on.

Using this model, it is no longer necessary for patients to interrupt their lives with trips to the hospital – which, in some cases, can be many miles away – for procedures that can take several hours to complete. They are not subject to the office hours of doctors and nurses, and have more ownership of their schedule in relation to the trial.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Sue Lee, Technical Portfolio Manager, has worked for World Courier for more than 25 years. During this time, she has experienced a variety of customer service and operational functions, including the setting up of numerous multinational clinical sites for the transportation of biological samples. Sue has orchestrated thousands of shipments with very specific temperature requirements to a host of challenging locations, each presenting their own obstacles and dilemmas.
spacer
Sue Lee
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera announces a better drug deposition with RetroNose to enhance therapeutic efficacy of nasal treatments

After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April 2017, Nemera is happy to publish enhanced drug deposition results compared to classic nasal sprays with RetroNose.
More info >>

White Papers

Crunch Time: The Impact of Serialisation Requirements on Packaging Operations

PCI Pharma Services

The deadlines for including unique product identifiers on prescription drugs is putting a strain on multiple parts of the industry, much of which is ill-prepared to meet the target. Here, we look to the experience of a company that is ahead of the curve for lessons on how to manage and ease the transition to serialisation.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement